Aamir Khan says method acting can excuse bad behaviour on set. His comments may reduce reputational risk for Bollywood studios he works with, shifting investor focus to production costs and talent contracts.
Aamir Khan told a Screen Academy Masterclass that he has directed only one film in 38 years – Taare Zameen Par – and that method acting sometimes gives actors “a lot of freedom to misbehave” by claiming to stay in character. The statement cuts against long-standing rumours that he secretly directs his own projects, and it reframes the debate around on-set professionalism in the Indian film industry.
For investors with exposure to Indian entertainment companies – whether through listed studios, streaming platforms, or theatrical operators – the reputational risk embedded in production culture is a hard-to-quantify but real factor. Method acting controversies have historically led to cost overruns, scheduling delays, and talent friction. Khan’s explicit rejection of that approach signals that Yash Raj Films, Dharma Productions, and other houses he works with may face fewer such risks on his projects.
Khan credited directors, writers, and technicians for the success of his films and said each project carries the unique vision of its filmmaker. That statement reinforces a director-led production model, which tends to produce more predictable budgets and clearer accountability. For a company like Reliance Entertainment (which co-finances several Khan films), the stability of that model can reduce earnings volatility from project to project.
On-set behaviour issues typically cascade into three measurable outcomes:
Khan’s public stance directly reduces the probability of that cascade on his sets. His 38-year track record of delivering commercially viable films – without the baggage of method-acting disruptions – makes him a lower-risk talent anchor for any production slate.
The practical question for an entertainment analyst or portfolio manager is not whether Aamir Khan’s opinion is correct. It is whether other A-list actors follow his lead. If the industry norm shifts away from method acting as a justification for poor behaviour, the risk premium baked into production company valuations should narrow. Conversely, if a major star publicly defends method acting in the face of Khan’s critique, that creates a divergent risk profile between actors and the studios that back them.
Investors should watch for:
The next concrete marker is the release of Khan’s next project. Pre-release buzz, production budget tracking, and media coverage of on-set behaviour will test whether this cultural signal translates into financial discipline.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.